{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:44:38Z","timestamp":1793324678991,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The disproportionately high prevalence of male cancer is poorly understood. We tested for sex-disparity in the functional integrity of the major tumor suppressor p53 in sporadic cancers. Our bioinformatics analyses expose three novel levels of p53 impact on sex-disparity in 12 non-reproductive cancer types. First, <jats:italic>TP53<\/jats:italic> mutation is more frequent in these cancers among US males than females, with poorest survival correlating with its mutation. Second, numerous X-linked genes are associated with p53, including vital genomic regulators. Males are at unique risk from alterations of their single copies of these genes. High expression of X-linked negative regulators of p53 in wild-type <jats:italic>TP53<\/jats:italic> cancers corresponds with reduced survival. Third, females exhibit an exceptional incidence of non-expressed mutations among p53-associated X-linked genes. Our data indicate that poor survival in males is contributed by high frequencies of <jats:italic>TP53<\/jats:italic> mutations and an inability to shield against deregulated X-linked genes that engage in p53 networks.<\/jats:p>","DOI":"10.1038\/s41467-019-13266-3","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T11:03:15Z","timestamp":1574766195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2484-1712","authenticated-orcid":false,"given":"Sue","family":"Haupt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-2544","authenticated-orcid":false,"given":"Franco","family":"Caramia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Herschtal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-3293","authenticated-orcid":false,"given":"Thierry","family":"Soussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8985-4886","authenticated-orcid":false,"given":"Guillermina","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-286X","authenticated-orcid":false,"given":"Han","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5403-7998","authenticated-orcid":false,"given":"Terence P.","family":"Speed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ygal","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"13266_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nrclinonc.2013.37","volume":"10","author":"MB Cook","year":"2013","unstructured":"Cook, M. B. Epidemiology: excess cancer in men-a call for an increased research focus. Nat. Rev. Clin. Oncol. 10, 186\u2013188 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"13266_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2016.04.001","volume":"29","author":"Y Yuan","year":"2016","unstructured":"Yuan, Y. et al. Comprehensive characterization of molecular differences in cancer between male and female patients. Cancer Cell 29, 711\u2013722 (2016).","journal-title":"Cancer Cell"},{"key":"13266_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/ng.3726","volume":"49","author":"A Dunford","year":"2017","unstructured":"Dunford, A. et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat. Genet. 49, 10\u201316 (2017).","journal-title":"Nat. Genet."},{"key":"13266_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s11764-016-0515-x","volume":"10","author":"DS Mowls","year":"2016","unstructured":"Mowls, D. S., Brame, L. S., Martinez, S. A. & Beebe, L. A. Lifestyle behaviors among US cancer survivors. J. Cancer Surviv. 10, 692\u2013698 (2016).","journal-title":"J. Cancer Surviv"},{"key":"13266_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/509282a","volume":"509","author":"JA Clayton","year":"2014","unstructured":"Clayton, J. A. & Collins, F. S. NIH to balance sex in cell and animal studies. Nature 509, 282\u2013283 (2014).","journal-title":"Nature"},{"key":"13266_CR6","doi-asserted-by":"crossref","unstructured":"Sulak, M. et al. TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants. eLife 5, e11994(2016).","DOI":"10.7554\/eLife.11994"},{"key":"13266_CR7","first-page":"6","volume":"3","author":"B Vogelstein","year":"2010","unstructured":"Vogelstein, B., Sur, S. & Prives, C. p53: The most frequently altered gene in human cancers. Nat. Educ. 3, 6 (2010).","journal-title":"Nat. Educ."},{"key":"13266_CR8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.4161\/cc.24805","volume":"12","author":"S Haupt","year":"2013","unstructured":"Haupt, S. et al. Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner. Cell Cycle 12, 1722\u20131731 (2013).","journal-title":"Cell Cycle"},{"key":"13266_CR9","doi-asserted-by":"publisher","first-page":"a000950","DOI":"10.1101\/cshperspect.a000950","volume":"1","author":"DW Meek","year":"2009","unstructured":"Meek, D. W. & Anderson, C. W. Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb. Perspect. Biol. 1, a000950 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"13266_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrc3711","volume":"14","author":"KT Bieging","year":"2014","unstructured":"Bieging, K. T., Mello, S. S. & Attardi, L. D. Unravelling mechanisms of p53-mediated tumour suppression. Nat. Rev. Cancer 14, 359\u2013370 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"13266_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57\u201362 (2015).","journal-title":"Nature"},{"key":"13266_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrm4007","volume":"16","author":"F Kruiswijk","year":"2015","unstructured":"Kruiswijk, F., Labuschagne, C. F. & Vousden, K. H. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat. Rev. Mol. Cell Biol. 16, 393\u2013405 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"13266_CR13","first-page":"1","volume":"8","author":"J Lowe","year":"2013","unstructured":"Lowe, J., Shatz, M., Resnick, M. A. & Menedez, D. Modulation of immune responses by the tumor suppresor p53. BioDiscovery 8, 1\u201312 (2013).","journal-title":"BioDiscovery"},{"key":"13266_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","volume":"29","author":"MD Vesely","year":"2011","unstructured":"Vesely, M. D., Kershaw, M. H., Schreiber, R. D. & Smyth, M. J. Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29, 235\u2013271 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"13266_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676\u2013689 e673 (2018).","journal-title":"Cancer Cell"},{"key":"13266_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc.2016.15","volume":"16","author":"G Stracquadanio","year":"2016","unstructured":"Stracquadanio, G. et al. The importance of p53 pathway genetics in inherited and somatic cancer genomes. Nat. Rev. Cancer 16, 251\u2013265 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"13266_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden, K. H. & Lane, D. P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275\u2013283 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"13266_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc3430","volume":"13","author":"M Wade","year":"2013","unstructured":"Wade, M., Li, Y. C. & Wahl, G. M. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat. Rev. Cancer 13, 83\u201396 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"13266_CR19","doi-asserted-by":"publisher","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier, M., Hollstein, M. & Hainaut, P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2, a001008 (2010).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"13266_CR20","first-page":"170","volume":"6","author":"Y Haupt","year":"2016","unstructured":"Haupt, Y. & Blandino, G. Editorial: human tumor-derived p53 mutants: a growing family of oncoproteins. Front Oncol. 6, 170 (2016).","journal-title":"Front Oncol."},{"key":"13266_CR21","unstructured":"Institute, N. C. Surveillance Epidemiology and End Results (SEER) Program. (http:\/\/www.seer.cancer.gov) SEER*Stat Database: Mortality - All COD, Aggregated With State, Total U.S. (2008-2012) <Katrina\/Rita Population Adjustment>, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released October 2014. Underlying mortality data provided by NCHS (http:\/\/www.cdc.gov\/nchs) (2014)."},{"key":"13266_CR22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"Cancer Genome Atlas Research, N.","year":"2013","unstructured":"Cancer Genome Atlas Research, N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"13266_CR23","doi-asserted-by":"publisher","unstructured":"Levine, A. J., Puzio-Kuter, A. M., Chan, C. S. & Hainaut, P. The role of the p53 protein in stem-cell biology and epigenetic regulation. Cold Spring Harb. Perspect. Med. 6, https:\/\/doi.org\/10.1101\/cshperspect.a026153 (2016).","DOI":"10.1101\/cshperspect.a026153"},{"key":"13266_CR24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.18632\/oncotarget.13483","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang, X. & Sun, Q. TP53 mutations, expression and interaction networks in human cancers. Oncotarget 8, 624\u2013643 (2017).","journal-title":"Oncotarget"},{"key":"13266_CR25","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","volume":"170","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber, E. R. & Lowe, S. W. Putting p53 in context. Cell 170, 1062\u20131078 (2017).","journal-title":"Cell"},{"key":"13266_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2217\/fon.12.26","volume":"8","author":"R Liu","year":"2012","unstructured":"Liu, R., Kain, M. & Wang, L. Inactivation of X-linked tumor suppressor genes in human cancer. Future Oncol. 8, 463\u2013481 (2012).","journal-title":"Future Oncol."},{"key":"13266_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ajhg.2013.03.017","volume":"92","author":"AL Wise","year":"2013","unstructured":"Wise, A. L., Gyi, L. & Manolio, T. A. eXclusion: toward integrating the X chromosome in genome-wide association analyses. Am. J. Hum. Genet. 92, 643\u2013647 (2013).","journal-title":"Am. J. Hum. Genet"},{"key":"13266_CR28","doi-asserted-by":"publisher","unstructured":"Accounting for sex in the genome. Nat. Med. 23, 1243, https:\/\/doi.org\/10.1038\/nm.4445 (2017).","DOI":"10.1038\/nm.4445"},{"key":"13266_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nrg3035","volume":"12","author":"A Wutz","year":"2011","unstructured":"Wutz, A. Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat. Rev. Genet. 12, 542\u2013553 (2011).","journal-title":"Nat. Rev. Genet"},{"key":"13266_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature03440","volume":"434","author":"MT Ross","year":"2005","unstructured":"Ross, M. T. et al. The DNA sequence of the human X chromosome. Nature 434, 325\u2013337 (2005).","journal-title":"Nature"},{"key":"13266_CR31","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk, D. et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 45, D362\u2013D368 (2017).","journal-title":"Nucleic Acids Res."},{"key":"13266_CR32","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/bies.201400032","volume":"36","author":"SB Peeters","year":"2014","unstructured":"Peeters, S. B., Cotton, A. M. & Brown, C. J. Variable escape from X-chromosome inactivation: identifying factors that tip the scales towards expression. Bioessays 36, 746\u2013756 (2014).","journal-title":"Bioessays"},{"key":"13266_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00439-011-1011-z","volume":"130","author":"JB Berletch","year":"2011","unstructured":"Berletch, J. B., Yang, F., Xu, J., Carrel, L. & Disteche, C. M. Genes that escape from X inactivation. Hum. Genet. 130, 237\u2013245 (2011).","journal-title":"Hum. Genet."},{"key":"13266_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/jmcb\/mjz007","volume":"11","author":"S Haupt","year":"2019","unstructured":"Haupt, S., Mejia-Hernandez, J. O., Vijayakumaran, R., Keam, S. P. & Haupt, Y. The long and the short of it: the MDM4 tail so far. J. Mol. Cell Biol. 11, 231\u2013244 (2019).","journal-title":"J. Mol. Cell Biol."},{"key":"13266_CR35","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1128\/MCB.05966-11","volume":"32","author":"S Chen","year":"2012","unstructured":"Chen, S., Wang, D. L., Liu, Y., Zhao, L. & Sun, F. L. RAD6 regulates the dosage of p53 by a combination of transcriptional and posttranscriptional mechanisms. Mol. Cell Biol. 32, 576\u2013587 (2012).","journal-title":"Mol. Cell Biol."},{"key":"13266_CR36","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/cdd.2011.173","volume":"19","author":"LY Peche","year":"2012","unstructured":"Peche, L. Y., Scolz, M., Ladelfa, M. F., Monte, M. & Schneider, C. MageA2 restrains cellular senescence by targeting the function of PMLIV\/p53 axis at the PML-NBs. Cell Death Differ. 19, 926\u2013936 (2012).","journal-title":"Cell Death Differ."},{"key":"13266_CR37","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1074\/jbc.M110.157842","volume":"286","author":"L Hu","year":"2011","unstructured":"Hu, L. et al. A small ribosomal subunit (SSU) processome component, the human U3 protein 14A (hUTP14A) binds p53 and promotes p53 degradation. J. Biol. Chem. 286, 3119\u20133128 (2011).","journal-title":"J. Biol. Chem."},{"key":"13266_CR38","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7150\/thno.21963","volume":"8","author":"J Xie","year":"2018","unstructured":"Xie, J. et al. CDK16 phosphorylates and degrades p53 to promote radioresistance and predicts prognosis in lung cancer. Theranostics 8, 650\u2013662 (2018).","journal-title":"Theranostics"},{"key":"13266_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep39222","volume":"7","author":"SY Park","year":"2017","unstructured":"Park, S. Y. et al. Protein serine\/threonine phosphatase PPEF-1 suppresses genotoxic stress response via dephosphorylation of PDCD5. Sci. Rep. 7, 39222 (2017).","journal-title":"Sci. Rep."},{"key":"13266_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1084\/jem.20111363","volume":"209","author":"Z Hao","year":"2012","unstructured":"Hao, Z. et al. The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. J. Exp. Med. 209, 173\u2013186 (2012).","journal-title":"J. Exp. Med"},{"key":"13266_CR41","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1093\/nar\/gkv325","volume":"43","author":"J Yi","year":"2015","unstructured":"Yi, J. et al. DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation. Nucleic Acids Res. 43, 4579\u20134590 (2015).","journal-title":"Nucleic Acids Res."},{"key":"13266_CR42","doi-asserted-by":"publisher","first-page":"25957","DOI":"10.1074\/jbc.M109.095950","volume":"285","author":"Y Kim","year":"2010","unstructured":"Kim, Y. et al. Cancer\/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs. J. Biol. Chem. 285, 25957\u201325968 (2010).","journal-title":"J. Biol. Chem."},{"key":"13266_CR43","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.freeradbiomed.2010.02.015","volume":"48","author":"R Puca","year":"2010","unstructured":"Puca, R. et al. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis. Free Radic. Biol. Med. 48, 1338\u20131346 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"13266_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccr.2005.06.006","volume":"8","author":"H Higashitsuji","year":"2005","unstructured":"Higashitsuji, H. et al. The oncoprotein gankyrin binds to MDM2\/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 8, 75\u2013p87 (2005).","journal-title":"Cancer Cell"},{"key":"13266_CR45","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S1097-2765(04)00123-6","volume":"13","author":"HH Li","year":"2004","unstructured":"Li, H. H., Li, A. G., Sheppard, H. M. & Liu, X. Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. Mol. Cell 13, 867\u2013878 (2004).","journal-title":"Mol. Cell"},{"key":"13266_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molcel.2013.10.031","volume":"53","author":"Y Wu","year":"2014","unstructured":"Wu, Y. et al. Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response. Mol. Cell 53, 63\u201374 (2014).","journal-title":"Mol. Cell"},{"key":"13266_CR47","doi-asserted-by":"publisher","first-page":"11160","DOI":"10.1073\/pnas.0510834103","volume":"103","author":"M Monte","year":"2006","unstructured":"Monte, M. et al. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc. Natl Acad. Sci. USA 103, 11160\u201311165 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13266_CR48","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1464-410X.2011.10433.x","volume":"109","author":"AP Noon","year":"2012","unstructured":"Noon, A. P. et al. Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy. BJU Int. 109, 1250\u20131257 (2012).","journal-title":"BJU Int"},{"key":"13266_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32264-x","volume":"8","author":"S Guerrero","year":"2018","unstructured":"Guerrero, S. et al. Analysis of racial\/ethnic representation in select basic and applied cancer research studies. Sci. Rep. 8, 13978 (2018).","journal-title":"Sci. Rep."},{"key":"13266_CR50","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/nm.2863","volume":"18","author":"A Gembarska","year":"2012","unstructured":"Gembarska, A. et al. MDM4 is a key therapeutic target in cutaneous melanoma. Nat. Med. 18, 1239\u20131247 (2012).","journal-title":"Nat. Med."},{"key":"13266_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41418-018-0246-9","volume":"26","author":"F Mantovani","year":"2019","unstructured":"Mantovani, F., Collavin, L. & Del Sal, G. Mutant p53 as a guardian of the cancer cell. Cell Death Differ. 26, 199\u2013212 (2019).","journal-title":"Cell Death Differ."},{"key":"13266_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6614a1","volume":"66","author":"SJ Henley","year":"2017","unstructured":"Henley, S. J. et al. Invasive cancer incidence, 2004-2013, and deaths, 2006-2015, in nonmetropolitan and metropolitan counties\u2014United States. MMWR Surveill. Summ. 66, 1\u201313 (2017).","journal-title":"MMWR Surveill. Summ."},{"key":"13266_CR53","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1172\/JCI71048","volume":"124","author":"T Sun","year":"2014","unstructured":"Sun, T. et al. Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males. J. Clin. Invest. 124, 4123\u20134133 (2014).","journal-title":"J. Clin. Invest"},{"key":"13266_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-018-0513-5","volume":"6","author":"N Kfoury","year":"2018","unstructured":"Kfoury, N. et al. Cooperative p16 and p21 action protects female astrocytes from transformation. Acta Neuropathol. Commun. 6, 12 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"13266_CR55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/jmcb\/mjx001","volume":"9","author":"X Zhou","year":"2017","unstructured":"Zhou, X., Cao, B. & Lu, H. Negative auto-regulators trap p53 in their web. J. Mol. Cell Biol. 9, 62\u201368 (2017).","journal-title":"J. Mol. Cell Biol."},{"key":"13266_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1550-8579(07)80024-6","volume":"4","author":"BR Migeon","year":"2007","unstructured":"Migeon, B. R. Why females are mosaics, X-chromosome inactivation, and sex differences in disease. Gend. Med 4, 97\u2013105 (2007).","journal-title":"Gend. Med"},{"key":"13266_CR57","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.celrep.2019.03.048","volume":"27","author":"ARD Delbridge","year":"2019","unstructured":"Delbridge, A. R. D. et al. Loss of p53 causes stochastic aberrant X-chromosome inactivation and female-specific neural tube defects. Cell Rep. 27, 442\u2013454 e445 (2019).","journal-title":"Cell Rep."},{"key":"13266_CR58","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/dneu.20581","volume":"68","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. Sex difference in neural tube defects in p53-null mice is caused by differences in the complement of X not Y genes. Dev. Neurobiol. 68, 265\u2013273 (2008).","journal-title":"Dev. Neurobiol."},{"key":"13266_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ccell.2018.11.009","volume":"35","author":"AJ Levine","year":"2019","unstructured":"Levine, A. J., Jenkins, N. A. & Copeland, N. G. The roles of initiating truncal mutations in human cancers: the order of mutations and tumor cell type matters. Cancer Cell 35, 10\u201315 (2019).","journal-title":"Cancer Cell"},{"key":"13266_CR60","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.18632\/oncotarget.13475","volume":"8","author":"K Hientz","year":"2017","unstructured":"Hientz, K., Mohr, A., Bhakta-Guha, D. & Efferth, T. The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget 8, 8921\u20138946 (2017).","journal-title":"Oncotarget"},{"key":"13266_CR61","first-page":"7362","volume":"15","author":"JD Shen","year":"2018","unstructured":"Shen, J. D. et al. High expression of ubiquitin-conjugating enzyme E2A predicts poor prognosis in hepatocellular carcinoma. Oncol. Lett. 15, 7362\u20137368 (2018).","journal-title":"Oncol. Lett."},{"key":"13266_CR62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2018.10.010","volume":"440-441","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc. Cancer Lett. 440-441, 106\u2013115 (2019).","journal-title":"Cancer Lett."},{"key":"13266_CR63","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3892\/ijo.2017.3984","volume":"50","author":"H Ujiie","year":"2017","unstructured":"Ujiie, H. et al. Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer. Int J. Oncol. 50, 2154\u20132170 (2017).","journal-title":"Int J. Oncol."},{"key":"13266_CR64","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.bbrc.2017.07.048","volume":"490","author":"M Terashima","year":"2017","unstructured":"Terashima, M., Ishimura, A., Wanna-Udom, S. & Suzuki, T. Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells. Biochem Biophys. Res. Commun. 490, 1407\u20131413 (2017).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"13266_CR65","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1158\/1078-0432.CCR-13-0351","volume":"19","author":"RS Warren","year":"2013","unstructured":"Warren, R. S. et al. Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803. Clin. Cancer Res. 19, 5777\u20135787 (2013).","journal-title":"Clin. Cancer Res."},{"key":"13266_CR66","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1158\/1541-7786.MCR-18-0551","volume":"17","author":"CH Chan","year":"2019","unstructured":"Chan, C. H., Chen, C. M., Lee, Y. W. & You, L. R. DNA damage, liver injury, and tumorigenesis: consequences of DDX3X loss. Mol. Cancer Res. 17, 555\u2013566 (2019).","journal-title":"Mol. Cancer Res."},{"key":"13266_CR67","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.celrep.2019.05.069","volume":"27","author":"B Phung","year":"2019","unstructured":"Phung, B. et al. The X-linked DDX3X RNA helicase dictates translation reprogramming and metastasis in melanoma. Cell Rep. 27, 3573\u20133586 e3577 (2019).","journal-title":"Cell Rep."},{"key":"13266_CR68","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.4161\/cc.19978","volume":"11","author":"P Moudry","year":"2012","unstructured":"Moudry, P. et al. Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage. Cell Cycle 11, 1573\u20131582 (2012).","journal-title":"Cell Cycle"},{"key":"13266_CR69","doi-asserted-by":"publisher","first-page":"e201800096","DOI":"10.26508\/lsa.201800096","volume":"1","author":"R Kumbhar","year":"2018","unstructured":"Kumbhar, R. et al. Recruitment of ubiquitin-activating enzyme UBA1 to DNA by poly(ADP-ribose) promotes ATR signalling. Life Sci. Alliance 1, e201800096 (2018).","journal-title":"Life Sci. Alliance"},{"key":"13266_CR70","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4161\/fly.4285","volume":"1","author":"CM Pfleger","year":"2007","unstructured":"Pfleger, C. M., Harvey, K. F., Yan, H. & Hariharan, I. K. Mutation of the gene encoding the ubiquitin activating enzyme ubal causes tissue overgrowth in Drosophila. Fly (Austin) 1, 95\u2013105 (2007).","journal-title":"Fly (Austin)"},{"key":"13266_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1242\/dev.011288","volume":"135","author":"TV Lee","year":"2008","unstructured":"Lee, T. V. et al. The E1 ubiquitin-activating enzyme Uba1 in Drosophila controls apoptosis autonomously and tissue growth non-autonomously. Development 135, 43\u201352 (2008).","journal-title":"Development"},{"key":"13266_CR72","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/ijc.27924","volume":"132","author":"PH Duijf","year":"2013","unstructured":"Duijf, P. H., Schultz, N. & Benezra, R. Cancer cells preferentially lose small chromosomes. Int J. Cancer 132, 2316\u20132326 (2013).","journal-title":"Int J. Cancer"},{"key":"13266_CR73","doi-asserted-by":"crossref","unstructured":"L\u00e9veill\u00e9,\u00a0N. et al. Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat. Commun. 6, 6520 (2015).","DOI":"10.1038\/ncomms7520"},{"key":"13266_CR74","doi-asserted-by":"crossref","unstructured":"Savoy, R. M. & Ghosh, P. M. The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it. Endocr. Relat. Cancer 20, R341\u2013356 (2013).","DOI":"10.1530\/ERC-13-0364"},{"key":"13266_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.molcel.2007.05.026","volume":"27","author":"AJ Donner","year":"2007","unstructured":"Donner, A. J., Szostek, S., Hoover, J. M. & Espinosa, J. M. CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol. Cell 27, 121\u2013133 (2007).","journal-title":"Mol. Cell"},{"key":"13266_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15194-y","volume":"7","author":"IK Mandemaker","year":"2017","unstructured":"Mandemaker, I. K. et al. DNA damage-induced histone H1 ubiquitylation is mediated by HUWE1 and stimulates the RNF8-RNF168 pathway. Sci. Rep. 7, 15353 (2017).","journal-title":"Sci. Rep."},{"key":"13266_CR77","doi-asserted-by":"publisher","first-page":"328ra328","DOI":"10.1126\/scitranslmed.aac8228","volume":"8","author":"C Koschmann","year":"2016","unstructured":"Koschmann, C. et al. ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma. Sci. Transl. Med. 8, 328ra328 (2016).","journal-title":"Sci. Transl. Med"},{"key":"13266_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum, P. R. & Rubin, D. B. The central role of the propensity score in observational studies for causal effects. Biometrika 70, 41\u201345 (1983).","journal-title":"Biometrika"},{"key":"13266_CR79","doi-asserted-by":"publisher","unstructured":"Broad Institute TCGA Genome Data Analysis Center (2016): Firehose stddata__2016_01_28 run. Broad Institute of MIT and Harvard. https:\/\/doi.org\/10.7908\/C11G0KM9 (2016).","DOI":"10.7908\/C11G0KM9"},{"key":"13266_CR80","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/ijb-2012-0030","volume":"9","author":"L Li","year":"2013","unstructured":"Li, L. & Greene, T. A weighting analogue to pair matching in propensity score analysis. Int J. Biostat. 9, 215\u2013234 (2013).","journal-title":"Int J. Biostat."},{"key":"13266_CR81","doi-asserted-by":"publisher","first-page":"E2423","DOI":"10.1002\/humu.22771","volume":"36","author":"AH Ramos","year":"2015","unstructured":"Ramos, A. H. et al. Oncotator: cancer variant annotation tool. Hum. Mutat. 36, E2423\u2013E2429 (2015).","journal-title":"Hum. Mutat."},{"key":"13266_CR82","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"13266_CR83","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"13266_CR84","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ajhg.2015.06.010","volume":"97","author":"CT Vicente","year":"2015","unstructured":"Vicente, C. T. et al. Long-range modulation of PAG1 expression by 8q21 allergy risk variants. Am. J. Hum. Genet. 97, 329\u2013336 (2015).","journal-title":"Am. J. Hum. Genet"},{"key":"13266_CR85","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res"},{"key":"13266_CR86","doi-asserted-by":"publisher","unstructured":"Sergushichev, A. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. BioRxiv\u00a0https:\/\/doi.org\/10.1101\/060012\u00a0(2016).","DOI":"10.1101\/060012"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13266-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T02:20:46Z","timestamp":1671243646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13266-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["13266"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-13266-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"9 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5385"}}